All News

Depression & Anxiety in Adults with Chronic Pain: A Meta-Analysis Review
April 28, 2025

Approximately 40% of adults with chronic pain have comorbid anxiety and/or depression, underscoring the importance of routine screening in this population.

AI Detects Nearly One-Third of Breast Cancers Previously Undetected by Radiologists on DBT Imaging
April 28, 2025

The AI program also correctly identified 90% of true positive cases, according to new data presented at the Society for Breast Imaging's annual symposium.

Moderate Preterm Birth Linked to Cognitive Deficits in Childhood in New Study
April 28, 2025

Children born before 34 weeks of gestation exhibited significant cognitive deficits by age 9-10, independent of genetic and socioeconomic factors, reported researchers.

Metabolic Syndrome Linked to Risk of Young Onset Dementia
April 28, 2025

Authors found a dose-response relationship between MetS and dementia onset in the 4th decade; in those with all 5 components, risk of dementia was increased by 77%.

Bacterial Vaginosis Recurrence Drops with Partner Treatment: Daily Dose
April 28, 2025

Your daily dose of the clinical news you may have missed.

Upadacitinib Found Effective in Achieving Remission in Crohn Disease, Including Biologic-Experienced Patients
April 25, 2025

Upadacitinib shows promising real-world effectiveness for managing moderate-to-severe Crohn disease, even in patients with prior treatment exposure.

Endemic Measles is a Clear and Present Danger, According to Stanford University Modeling Study
April 25, 2025

At current vaccination rates, measles could become endemic in the US again within 21 years; the threat extends to rubella, polio, and diphtheria, the study found.

Postpartum Hormonal Contraceptive Use Linked to Increased Risk of Depression
April 25, 2025

The increased risk of depression when oral contraceptives were started following childbirth was "instantaneous," researchers wrote, and was ~50% greater than nonuse.

Precision Obesity Medicine Breakthroughs To Lead DDW 2025 Presentations from Phenomix Sciences
April 25, 2025

Phenomix will showcase new data on prediction of adverse events to GLP-1 RA therapy, a new obesity sub-phenotype, and approaches to improve surgical outcomes.

Oral Semaglutide Cuts MACE Risk by 14% in High-Risk Adults: Daily Dose
April 25, 2025

Your daily dose of the clinical news you may have missed.